Has Lennox Archibald received payments from drug or device companies?

Yes. Drug and device makers reported $2,121,297 in general payments to Lennox Archibald across 882 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lennox Archibald did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lennox Archibald come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lennox Archibald

Infectious Disease · Gainesville, FLNPI 1477728111

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,532,733 of the $2,121,297 with a category attached, or 72.3%. 7 manufacturers reported payments, led by RTI Surgical, Inc at 28.2% of the total. Reporting peaked in 2019 at $496,051 and has fallen 84.9% since, to $74,800 in 2025. Among infectious disease clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,121,297in general payments, 2019–2025

Across 882 payments — averaging $2405.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

RTI Surgical, Inc$597K
Globus Medical$588K
Axogen$500K
Surgalign Spine Technologies, Inc.$436K
Geistlich Pharma, North America, Inc.$87
Melinta Therapeutics, LLC$39
plus $20 from 1 others

$11,889in research payments, 2019–2025

Across 2 payments — averaging $5944.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Geistlich Pharma, North America, Inc.$12K

What the payments were for

Consulting fees$1,532,73372%
Speaking & faculty fees$587,60028%
Travel & lodging$6070%
Food & beverage$3580%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
RTI Surgical, Inc	34	$597,320
Globus Medical	784	$587,997
Axogen	37	$499,875
Surgalign Spine Technologies, Inc.	23	$435,960
Geistlich Pharma, North America, Inc.	1	$87
Melinta Therapeutics, LLC	2	$39
Integra Lifesciences Corporation	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,121,297 in reported general payments places this provider in the 95th percentile of 669 infectious disease providers in Florida.

See all infectious disease providers in Florida →

Other infectious disease in Gainesville

Cornelius ClancyGainesville$93K
Moti RamgopalFort Pierce$1.1M
Juan DiazAltamonte Springs$980K
Charlotte-Paige RolleOrlando$619K
Kenneth AlexanderOrlando$474K
Douglas BrustMiami$359K
Christopher CooperAltamonte Springs$278K
Federico HinestrosaOrlando$276K
Cynthia RiveraMiami Beach$265K
Sally AlrabaaTampa$250K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →